drugset / Trial / NCT01450098
A Study of LY2484595 in Healthy Subjects
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study will be to evaluate the safety of a single dose of LY2484595 and to compare the amount of LY2484595 in the blood of healthy non-Asian subjects, Chinese subjects, and first-generation Japanese subjects after receiving a single oral dose of LY2484595 in a fasted state, after eating a low-fat meal, and after eating a high-fat meal.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evacetrapib | Small molecule | 100 mg | Oral |
| Subject | Evacetrapib | Small molecule | 200 mg | Oral |
| Subject | Evacetrapib | Small molecule | 300 mg | Oral |
Indications
No indication recorded.